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The discovery that hematopoietic human colony
stimulating factor-1 receptor (CSF-1R) can be acti-
vated by two distinct cognate cytokines, colony
stimulating factor-1 (CSF-1) and interleukin-34 (IL-
34), created puzzling scenarios for the two possible
signaling complexes.We here employ a hybrid struc-
tural approach based on small-angle X-ray scattering
(SAXS) and negative-stain EM to reveal that bivalent
binding of human IL-34 to CSF-1R leads to an extra-
cellular assembly hallmarked by striking similarities
to the CSF-1:CSF-1R complex, including homotypic
receptor-receptor interactions. Thus, IL-34 and
CSF-1 have evolved to exploit the geometric require-
ments of CSF-1R activation. Our models include
N-linked oligomannose glycans derived from a
systematic approach resulting in the accurate fitting
of glycosylated models to the SAXS data. We further
show that the C-terminal region of IL-34 is heavily
glycosylated and that it can be proteolytically
cleaved from the IL-34:hCSF-1R complex, providing
insights into its role in the functional nonredundancy
of IL-34 and CSF-1.
INTRODUCTION
The hematopoietic colony stimulating factor-1 receptor (CSF-1R
or c-fms), a class III receptor tyrosine kinase (RTK-III) featuring
five Ig-like extracellular domains (Lemmon and Schlessinger,
2010; Verstraete and Savvides, 2012), is activated by its two
cytokine ligands, CSF-1 and interleukin 34 (IL-34), to establish
signaling cascades leading to the proliferation, differentiation,528 Structure 21, 528–539, April 2, 2013 ª2013 Elsevier Ltd All rightsand functionality of cells derived from the mononuclear phago-
cytic lineage, such as monocytes, tissue macrophages, micro-
glia, osteoclasts, and antigen-presenting dendritic cells (Chitu
and Stanley, 2006; Hamilton and Achuthan, 2012; Verstraete
and Savvides, 2012). Furthermore, signaling via wild-type
hCSF-1R and mutants thereof has been implicated in a wide
rangeof pathologies in humans, suchasarthritis, atherosclerosis,
tumor growth, and metastasis (Verstraete and Savvides, 2012).
Over the last decade the molecular basis of CSF-1R activation
has taken an unexpected twist when csf1r / mice were found
to exhibit a stronger phenotype than csf1op/op mice (Dai et al.,
2002), which suggested the possibility of CSF-1-independent
activation of CSF-1R. Thus, the recent discovery that IL-34,
a cytokine sharing no recognizable sequence similarity to the
prototypical CSF-1R ligand CSF-1 (Lin et al., 2008), serves as
a second ligand to CSF-1R essentially established CSF-1R as
perhaps the most intriguing member of the RTK-III family. IL-34
can fully rescue the phenotype of csf1op/op micewhen expressed
in a CSF-1-specific manner (Wei et al., 2010), and like CSF-1,
IL-34 stimulates monocyte survival, macrophage proliferation,
osteoclast formation/differentiation, and is involved in the
development of microglia (Baud’huin et al., 2010; Lin et al.,
2008; Mizuno et al., 2011). Despite such seemingly functional
equivalence, important differences do exist. For instance, IL-34
causes a stronger and more rapidly declining phosphorylation
of CSF-1R when compared to CSF-1 (Chihara et al., 2010).
Moreover, analysis of mRNA expression levels in embryonic
and adult mouse tissues revealed that IL-34 is expressed
differentially from CSF-1, resulting in higher IL-34 mRNA levels
in the postnatal and adult brain, salivary glands, and ear (Wei
et al., 2010). Finally, recent studies have identified additional
functionalities for IL-34 as a key growth factor for the develop-
ment of Langerhans cells from myeloid cells in the skin (Greter
et al., 2012; Wang et al., 2012).
The duality of CSF-1R activation and the lack of sequence
homology between CSF-1 and IL-34, inevitably establishedreserved
Structure
Extracellular Complex of Human IL-34 with CSF-1Ra structural conjecture as to possible differences and similarities
in the structural basis of CSF-1R activation by IL-34 and CSF-1.
Structural studies on human and mouse CSF-1R ectodomains
in complex with cognate CSF-1 demonstrated that despite the
restrictive species cross-reactivity of CSF-1 and CSF-1R (Gar-
ceau et al., 2010; Gow et al., 2012a, 2012b), CSF-1:CSF-1R
complexes share important commonalities (Chen et al., 2008;
Elegheert et al., 2011). These are hallmarked by the bivalent
binding of CSF-1 to CSF-1R to establish interaction interfaces
with extracellular Ig-like domains D2 and D3 in CSF-1R
and the ensuing homotypic receptor-receptor interaction
between the membrane-proximal D4 domains of CSF-1R. In
addition, the elucidation of the mechanism by which the viral
decoy receptor BARF1 allosterically inactivates human CSF-1
has led to a deconvolution of the cooperative and modular
character of CSF-1:CSF-1R complexes (Elegheert et al., 2012).
We here build on recent exciting developments in the struc-
tural biology of human and mouse IL-34:CSF-1R complexes
that revealed the structure of the IL-34 core (a construct devoid
of 50 C-terminal residues) and the structural details of its interac-
tion with the first three extracellular domains of CSF-1R (CSF-
1RD1-D3) (Liu et al., 2012; Ma et al., 2012). In particular, our study
has sought to provide structural insights into the assembly
principles underlying the complete human IL-34:CSF-1R extra-
cellular complex and to investigate the possibility of a structural
consensus between IL-34 and CSF-1 complexes with their
common receptor. Such insights would complete an unprece-
dented series of snapshots of full-length RTK-III ectodomains
in complex with their cognate helical cytokines (Elegheert
et al., 2011; Verstraete et al., 2011b; Yuzawa et al., 2007),
thereby establishing the repertoire of their structural and mech-
anistic features (Verstraete and Savvides, 2012). This has
become especially important at a time when somatic mutations
identified in RTK-III ectodomains continue to emerge from
genomic analyses of tumor and cancer cells (Verstraete and
Savvides, 2012). In parallel, our study addresses the role and
structural characteristics of the C-terminal tail of IL-34, a 50-
residue sequence that has been excluded from all previous
structural studies.
RESULTS
Isolation and Biochemical Characterization of IL-34
Complexes with CSF-1R Ectodomains
Production of recombinant human hIL-34 and hCSF-1R ectodo-
main variants (Elegheert et al., 2011) for structural studies was
initially carried out via transient expression in HEK293T cells in
the presence of kifunensine (Chang et al., 2007). However, yields
for the two target constructs of IL-34, i.e., full-length hIL-34
(hIL-34FL) and hIL-34N21-P200 featuring a C-terminal deletion to
exclude the predicted inherently unstructured region (Yang
et al., 2005), were prohibitively low. To circumvent this problem,
we established stable tetracycline-inducible HEK293S GnTI/
cell lines (Reeves et al., 2002; Verstraete et al., 2011a) expressing
high amounts of recombinant hIL-34 (typically 2 mg per liter
of expression medium), which offered the additional benefit
of homogeneous N-linked glycosylation with GlcNAc2Man5.
We further exploited this key tool to produce IL34:CSF-1R
complexes (hIL34:hCSF-1RD1-D3 and hIL34:hCSF-1RD1-D5) byStructure 21transfecting our stable cell lines expressing IL-34 with the appro-
priate receptor construct. The ensuing purification of recombi-
nant hIL-34:hCSF-1R complexes by immobilized metal affinity
chromatography (IMAC) and size-exclusion chromatography
(SEC) led to highly monodisperse preparations approaching
yields of 1 mg per liter of expression medium (Figure 1A).
To probe the possible stoichiometry of our recombinant
complexes, multiangle laser light scattering (MALLS) experi-
ments were carried out using a force field fractionation (FFF)
module (Figure 1B). Our analysis revealed molecular weights
that are consistent with predicted N- and O-linked glycosylation
in IL-34 andCSF-1R (Gupta et al., 2004; Julenius et al., 2005) and
strongly suggested that all three recombinant complexes corre-
spond to ternary assemblies whereby dimeric hIL-34 ligand
binds two receptor molecules.
Structure of the Complete Extracellular Assembly
of the IL-34:CSF-1R Complex
To elucidate the extracellular assembly of the hIL-34:hCSF-
1RD1-D5 complex, we pursued a combined approach featuring
structural characterization of hIL-34:hCSF-1R complexes in
solution via SAXS and direct visualization of the complex using
negative stain electron microscopy (EM).
We used highly monodisperse preparations of purified re-
combinant hIL-34FL:hCSF-1RD1-D5 and hIL-34N21-P200:hCSF-
1RD1-D5 to measure SAXS data at several concentrations of
the complex (Figures S1A and S1B available online). Despite
the overall good quality of both SAXS data sets (Table S1; Fig-
ures S1A and S1B), we were only able to obtain robust ab initio
models with good clustering behavior for the hIL-34N21-P200:
hCSF-1RD1-D5 complex. The predicted inherent structural
flexibility and heavy glycosylation of the long C-terminal tail are
likely reasons for this behavior. Nonetheless, we note that the
distance distribution functions for hIL-34FL:hCSF-1RD1-D5 and
hIL-34N21-P200:hCSF-1RD1-D5 complexes suggest adoption of
similar shapes by the two complexes (Figure S1E), albeit with
the hIL-34FL:hCSF-1RD1-D5 complex being slightly larger as indi-
cated by the Dmax and I0 values (Figures S1E and S1F). This
suggests that the C-terminal 50 residues in hIL-34 do not
substantially contribute to the overall shape of the complex
and that they likely adopt a highly flexible structure. Ab initio
modeling of the hIL-34N21-P200:hCSF-1RD1-D5 complex led to
a molecular envelope featuring a central triangular toroid deco-
rated with appendages at each vertex (Figure S2A). We subse-
quently used available crystal structures for hIL-34N21-V193 and
complexes thereof with hCSF-1RD1-D3 (Ma et al., 2012) and
homology models for hCSF-1RD4 and hCSF-1RD5 derived from
KIT (Yuzawa et al., 2007) to reconstruct the assembly of the
hIL-34N21-P200:hCSF-1RD1-D5 complex (Figure 2) by restrained
rigid-body modeling. A key methodological implementation in
our modeling approach concerned the inclusion of N-linked
oligomannose glycans (GlcNAc2Man5) and missing loop regions
(Choi and Deane, 2010), which were optimized with the help of
molecular dynamics and energy-minimization protocols (Phillips
et al., 2005). We based our selection of candidate N-linked
glycosylation sites on the crystal structure of hIL-34N21-V193:
hCSF-1RD1-D3, which clearly shows electron density for the first
GlcNAc residue at residues Asn75 in hIL34N21-V193 and Asn73,
Asn153, Asn240, and Asn275 in hCSF-1RD1-D3. In particular,, 528–539, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 529
Figure 1. Biochemical Characterization
of hIL-34FL:hCSF-1RD1-D5, hIL-34N21-P200:
hCSF1-RD1-D5, and hIL-34N21-P200:hCSF-
1RD1-D3 Complexes
(A) SEC profiles of hIL-34FL:hCSF-1RD1-D5 (green),
hIL-34N21-P200:hCSF-1RD1-D5 (blue), and hIL-
34N21-P200:hCSF-1RD1-D3 (red) complexes. The
profiles are accompanied by insets showing
SDS-PAGE analysis of peak fractions (R, receptor;
L, ligand). Details on purification of the complexes
can be found in the Experimental Procedures.
(B) Molecular weight determination of hIL-
34FL:hCSF-1RD1-D5 (green), hIL-34N21-P200:hCSF-
1RD1-D5 (blue), and hIL-34N21-P200:hCSF-1RD1-D3
(red) by MALLS. The differential refractive index
signal of the different complexes is plotted as a
function of the elution time after FFF. The derived
molecular weights are shown together with the
fits (black lines) to the MALLS data.
Structure
Extracellular Complex of Human IL-34 with CSF-1Rwe note that modeling of glycan trees, accounting for almost
10% of the total scattering mass (Table S1), provided dramatic
improvements in the agreement between models and experi-
mental data (Figure 2A; Table S1) and has essentially been
a crucial experimental parameter.
The structure of the hIL-34N21-P200:hCSF-1RD1-D5 complex
as derived from SAXS data revealed a ternary assembly in which
an IL-34 dimer bivalently binds to two copies of CSF-1R evoking
homotypic D4-D4’ receptor contacts Figures 2A and 2B). CSF-
1R employs D2 and D3 to form the cytokine binding site. At the
same time, the N-terminal D1 domains of CSF-1R emanate
outward without making any contacts with other components
of the complex, whereas the membrane-proximal D5 domains
diverge from each other without contacting one another (Fig-
ure 2B). We further note that the glycan trees also largely diverge
away from the body of the complex, suggesting that they are not
involved in specific interactionswith components of the complex.
Parallel to structural studies of the complex by SAXS, we
sought to image full-length human IL-34 (hIL-34FL) in complex
with hCSF-1RD1-D5 via negative stain EM. The added value of
this undertaking was the possibility to structurally probe for the
first time the complex of intact hIL-34 with the complete ectodo-
main of hCSF-1R and to cross-validate the structural features
revealed by our SAXS analysis of truncated IL-34 in complex
with hCSF-1R. Imaging of negative-stained hIL-3 4FL:hCSF-
1RD1-D5 (Figure 1), followed by multivariate statistical analysis
(MSA) and classification of about 12,000 particles, resulted
in a set of class averages featuring pronounced similarities to530 Structure 21, 528–539, April 2, 2013 ª2013 Elsevier Ltd All rights reservedour models of the hIL-34N21-P200:hCSF-
1RD1-D5 complex as derived from SAXS
data (Figure 2C). To better compare these
class averages with the models derived
from SAXS, the classes were oriented
to matching projections of the hIL-
34N21-P200:hCSF-1RD1-D5 model filtered
to 30 A˚ resolution. Our analysis reveals
that all major features observed in the
SAXS models are well conserved in the
EM class averages (Figure 2C). Further-more, the EM classes are devoid of additional features that
could correspond to the C-terminal tail of hIL-34, lending further
support to the flexibility of this region.
Encouraged by our approach for obtaining accurate SAXS-
derived glycosylated models of cytokine-receptor complexes,
we wondered whether it would be possible to obtain a complete
model for the hCSF-1:hCSF-1RD1-D5 complex from analysis
of SAXS data. The architecture of this complex was recently
characterized by three-dimensional (3D)-reconstruction of
negatively stained images of the complex obtained by EM
(Elegheert et al., 2011). Indeed, addition of N-linked glycans, in
conjunction with a careful restraints model taking into account
known interaction interfaces in the hCSF1:hCSF-1R complex,
led to a model that agreed very well with experimental data
(Figure 3A). Superposition of this model to the EM density map
for the hCSF-1:hCSF-1RD1-D5 complex (Elegheert et al., 2011)
shows that the overall features and architecture of the complex
are largely similar (Figure 3B), thus lending support to such
dual approach for characterizing macromolecular assemblies.
To verify whether the proposed models for hIL-34:CSF-
1RD1-D5 and hCSF-1:CSF1RD1-D5 would be consistent through-
out different modeling runs against the experimental SAXS
data, ten identical SASREF refinement protocols each with a
distinct seed number were carried out in parallel for the two
assemblies (Figure S3). Our results show that the core of the
complexes defined by the bound cytokines and hCSF-1RD2-D4,
refined to nearly identical structures in all models, with glycans
on CSF-1RD2-D4 pointing consistently outward. Interestingly, D1
Figure 2. Structural Analysis of the hIL-34:hCSF-1RD1-D5 Complex by SAXS and Negative Stain EM
(A) SAXS analysis of hIL-34N21-P200:hCSF-1RD1-D5. The left panel shows calculated scattering curves for hIL-34N21-P200:hCSF-1RD1-D5 rigid-body models
generated by SASREF and their fits to the experimental data (black curves). The different fits are put on a relative scale for better visualization. The red
curve represents the calculated curve from a SASREF-generated rigid-body model for hIL-34N21-P200:hCSF-1RD1-D5 using hIL-34N21-V193:hCSF-1RD2-D3 (PDB
ID code 4DKD) as a rigid core, while allowing hCSF-1RD1 to move by using distance restraints between hCSF1-RD1 and hCSF-1RD2. hCSF-1RD4 and
hCSF-1RD5 were modeled by I-Tasser using D4 and D5 of the KIT receptor (PDB ID code 2E9W) as templates. Additional distance restraints were specified
between hCSF-1RD3 and hCSF-1D4, between hCSF-1RD4 and hCSF-1D5, and between neighboring hCSF-1RD4 domains. The green curve represents the
calculated curve from a SASREF-generated rigid-body model using the same restraints as described above but with added GlcNAc2Man5 N-glycans on N75
of hIL34N21-V193 and N73, N153, N240, N275, and N353 of hCSF-1RD1-D5 (yellow). The upper-right panel shows the calculated distance distribution of the
different hIL-34N21-P200:hCSF-1RD1-D5 SASREFmodels (red, without N-glycans; green, with N-glycans) and the distance distribution function of the experimental
data in gray. Distance distribution functions were scaled to unity allowing better comparison. The lower-right panel shows calculated Guinier regions of the
different hIL-34N21-P200:hCSF-1RD1-D5 SASREF models (red, without N-glycans; green, with N-glycans) and the Guinier region of the experimental data in black.
The data range used for fitting is indicated as a light-gray box. See also the Experimental Procedures; Table S1; Figure S1.
(B) Three representative views of the hIL-34N21-P200:hCSF-1RD1-D5 complex in ribbon representation as derived from SAXS data.
(C) Negative stain EM of the hIL-34FL:hCSF-1RD1-D5 complex. Representative EM class averages (upper row) are shown along with projections of the rigid-body
SAXS model for hIL-34N21-P200:hCSF-1RD1-D5 (lower row) blurred to 30 A˚ resolution for visual comparison. See also Figures S2 and S3; Table S3.
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Extracellular Complex of Human IL-34 with CSF-1Rand D5 of CSF-1R adopted markedly more variable conforma-
tional states about the D1-D2 and D4-D5 hinge regions, resulting
in an ensemble of structures (Figure S3). We note that in each
case D1-D1’ and D5-D50 pairs concertedly point away from the
central axis of the complex at various degrees of separation
without making any contacts in any case. Nonetheless, each
of the models in the clusters fitted equally well to the data (IL-
34:CSF-1R, mean c2 = 0.97 ± 0.13; CSF-1:CSF-1R, mean c2 =
1.11±0.17) and showed ahighly similar overall shape (FigureS3),
corroborating the robustness of our individual models.
Although our study highlights the importance of including
glycans in the SAXS modeling of glycosylated proteins, surpris-
ingly only a handful of studies have adopted similar approaches.
For instance, N-linked glycans can be added to the protein using
the GlyProt server (Kajander et al., 2011; Rathore et al., 2012),
they can be modeled as flexible residues using MODELER
(Guttman et al., 2012), or they can be added as movable rigid
bodies in SASREF (Alt et al., 2012; Zeev-Ben-Mordehai et al.,Structure 212009), although this approach is limited by the number of
allowable rigid bodies. Our method allows effective modeling
of glycans in glycosylated proteins against SAXS data by com-
bining SASREF-based rigid-body modeling of starting struc-
tures, adding missing gaps/loops, and performing subsequent
energy minimization runs to obtain stereochemically sound
models. This modeling strategy can serve as an alternative
option to the recently developed AllosMod-FoXS server, which
combines MODELER-based glycan modeling with molecular
dynamics optimization of generated ensembles using AllosMod
(Weinkam et al., 2012), followed by comparisons of calculated
scattering patterns to the experimental data using FoXS
(Schneidman-Duhovny et al., 2010).
IL-34 Establishes a Ternary Complex in the Absence
of the Receptor Membrane-Proximal Domains
In light of the recent crystal structure of hIL-34 in complex with
hCSF-1RD1-D3, describing a binary complex instead of the, 528–539, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 531
Figure 3. Structural Assembly of the hCSF-
1:hCSF-1RD1-D5 Complex Derived from
SAXS Data
(A) A reanalysis of available SAXS data for the
hCSF-1:hCSF-1RD1-D5 complex. The left panel
shows the fits between the experimental data
(black curves) and calculated scattering curves
for hCSF-1:hCSF-1RD1-D5 rigid-body models
generated by SASREF with (green) or without
(red) modeled N-glycans, whereas the right
panels show the distance distribution functions
(upper-right) and Guinier region analysis (lower-
right). Modeling was performed with identical
restraints as described for hIL-34N21-P200:hCSF-
1RD1-D5, except for the replacement of the
hIL-34N21-V193:hCSF-1RD2-D3 rigid core by mouse
CSF-1:CSF-1RD2-D3 (Chen et al., 2008) (PDB ID
code 3EJJ). See also the Experimental proce-
dures; Table S1; Figure S1.
(B) Superposition of the rigid-body SAXS model
and an EM density map for CSF-1:CSF-1RD1-D5
(Elegheert et al., 2011) (the Electron Microscopy
Data Bank accession code EMD-1977). The
rigid-body SAXS model was manually placed in
the EM density map (white). See also Figure S3;
Table S3.
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Extracellular Complex of Human IL-34 with CSF-1Rexpected ternary assembly as suggested by binding studies via
isothermal titration calorimetry (Ma et al., 2012) and a ternary
complex for mouse IL-34:CSF-1RD1-D3 (Liu et al., 2012), we
pursued characterization of hIL-34N21-P200:hCSF-1RD1-D3 by
SAXS. Indeed, fitting of the binary hIL-34N21-V193:hCSF-1RD1-D3
complex to the SAXS data revealed a gross incompatibility
with the experimental scattering data (Figure 4, red curve). A
systematic exploration of binary and ternary complexes derived
from the crystal structure of hIL-34:hCSF-1RD1-D3 and refined
models thereof via restrained rigid-body refinement (including
modeling of glycans and/or allowing flexibility of CSF-1RD1) (Fig-
ure 4) showed that by far the best model was the glycosylated
ternary assembly with hCSF-1D1 pointing upward (Figure 4,
green curve). This finding confirms that a stable ternary complex
hIL-34:hCSF-1RD1-D3 exists in solution, consistent with our532 Structure 21, 528–539, April 2, 2013 ª2013 Elsevier Ltd All rights reservedMALLS analyses of the complex (Fig-
ure 1). We further note that the molecular
architecture of this subcomplex is very
similar to its counterpart in our full-length
ectodomain complex (Figure 2).
The C-Terminal Region of IL-34 Is
Heavily Glycosylated
Recent studies had shown that the last
40 residues at the C terminus of IL-34
are dispensable for receptor binding
and activation (Chihara et al., 2010; Ma
et al., 2012), yet no other biochemical
or structural information has become
available for this region. In fact, all avail-
able crystal structures for IL-34, either
alone or in complex with CSF-1RD1-D3,
are based on truncated IL-34 constructslacking this region. Indeed, a bioinformatics analysis to identify
potential inherently disordered regions in full-length human
and mouse IL-34 sequences (Yang et al., 2005) identifies a
contiguous stretch of about 50 amino acids at the C terminus
as a candidate inherently unstructured region, and subsequent
prediction of N- and O-linked glycosylation indicates eight
potential O-linked glycosylation sites (Julenius et al., 2005;
Nishikawa et al., 2010) and no N-linked glycan sites.
We thus wondered what the domain character of this
C-terminal segment might be and whether this segment
might be glycosylated, according to predictions. Limited prote-
olysis experiments on the purified hIL-34FL:hCSF-1RD1-D5
complex (Figure 1) followed by staining of SDS-PAGE gels with
Coomassie blue and glycostain led to a set of distinct mole-
cular species (Figure 5A). On one hand, hIL-34 migrated as
Figure 4. Structural Characterization
the hIL-34N21-P200:hCSF-1RD1-D3 Ternary
Complex
SAXS analysis of hIL-34N21-P200:hCSF-1RD1-D3.
The left panel shows the fits between the experi-
mental data (black curves) and calculated scat-
tering curves for different hIL-34:hCSF-1RD1-D3
structures/models along with their respective c2
values. The different fits are put on a relative scale
for better visualization. The red curve shows
the calculated curve from the crystal structure
of the binary hIL-34N21-V193:hCSF-1RD1-D3 com-
plex (Ma et al., 2012) (PDB ID code 4DKD). The
orange curve shows the calculated curve from
a generated ternary complex based on the hIL-
34N21-V193:hCSF-1RD1-D3 crystal structure with a
second hCSF-1RD1-D3molecule by applying 2-fold
symmetry. The blue curve shows the calculated
curve from a SASREF-generated rigid-body
model using hIL-34N21-V193:hCSF-1RD2-D3 (PDB ID
code 4DKD) as a rigid core, while allowing hCSF-
1RD1 to move by using 5 A˚ distance restraints
between hCSF1-RD1 and hCSF-1RD2. The green
curve shows the calculated curve from a SASREF-
generated rigid-body model with identical
restraints as the previous model (blue) but with
added GlcNAc2Man5 N-glycans (shown in yellow)
on N75 of hIL3434N21-V193 and N73, N153, N240,
and N275 of hCSF-1RD1-D3. The upper-right panel
shows the calculated distance distribution of the
different hIL-34:hCSF-1RD1-D3 structures/models
(red, orange, blue, and green) and the distance
distribution function of the experimental data in
gray. Distance distribution functions were scaled
to unity allowing better comparison. The lower-
right panel shows calculated Guinier regions of
the different hIL-34:hCSF-1RD1-D3 structures/models (red, orange, blue, and green) and the Guinier region of the experimental data in black. The data range used
for fitting is indicated as a light-gray box. See also the Experimental Procedures; Tables S1 and S3; Figures S1 and S2.
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Extracellular Complex of Human IL-34 with CSF-1Ra 25 kDa protein (hIL-34TRUNC) compared to its native 35–
40 kDa form, whereas hCSF-1RD1-D5 was reduced to a
50 kDa species (hCSF-1RTRUNC) from its original apparent
molecular weight of 75 kDa (Figure 5A). hIL-34TRUNC generated
by limited proteolysis has the same electrophoretic mobility as
our hIL-34N21-P200 construct, which lacks the last 42 C-terminal
residues. Despite the clear signal for hIL-34FL via Coomassie
staining and glycan staining, and the preservation of good signal
for hIL-34TRUNC via Coomassie staining, almost no signal is
retained for hIL-34TRUNC according to glycan staining. This
indicates that truncation of hIL-34FL to hIL-34TRUNC results in
a drastic reduction of glycan content. To identify the domain
composition of these truncated IL-34 and CSF-1R species,
a mass spectrometric analysis was performed using MALDI-
TOF/TOF (Figure 5B). Our analysis revealed that upon limited
proteolysis hIL-34FL in the hIL-34FL:hCSF-1RD1-D5 complex is
truncated at its C terminus to yield hIL-34TRUNC. Furthermore,
hCSF-1RD1-D5 loses the entire D5. To investigate the intactness
of the native N termini in hIL-34TRUNC and hCSF-1RTRUNC, we
performed Edman degradation (Figure 5C), which confirmed
that both native N termini were present. We also measured the
molecular (MW) of hIL-34FL by linear modeMALDI-TOF analysis,
revealing a MW of approximately 31 kDa for the fully glycosy-
lated protein. Such MW differs by 5 kDa from the theoreticalStructure 21MW of 26 kDa. As O-glycosylation in HEK293 cells was recently
shown to be of theGalNAc-NeuNAc-Gal-NeuNAc type (Geoghe-
gan et al., 2013), we can deduce that at least five O-linked
glycans must be present in the C-terminal segment of hIL-34FL.
Our findings confirm that the C terminus of hIL-34FL is heavily
glycosylated via O-linked glycans, providing insights into the
already observed differences between IL-34 and CSF-1 in terms
of functionality and signaling activation patterns (Chihara et al.,
2010). Indeed, O-glycosylation in signaling molecules plays a
role in protein stability, clearance, and/or modulation of its
signaling activity (Van den Steen et al., 1998). Interestingly,
O-glycosylation of the mucin type (O-GalNAc) preferentially
occurs in inherently disordered regions (Nishikawa et al.,
2010). We envisage that our findings will stimulate further
research on the dissection of glycosylation in the C-terminal
tail of IL-34 and its functional role.
DISCUSSION
The discovery of IL-34 as a second cytokine ligand for hema-
topoietic CSF-1R has raised intriguing structural and mecha-
nistic questions as to how two cytokines with unidentifiable
sequence homology might activate the same cognate receptor.
This has also created a potential avenue to shed light into the, 528–539, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 533
Figure 5. Limited Proteolysis of the hIL-34FL:hCSF1-RD1-D5 Complex followed by SDS-PAGE Analysis, MALDI-TOF/TOF MSMS Analysis,
and Edman Degradation
(A) SDS-PAGE analysis of hIL-34FL:hCSF1-RD1-D5 after incubation with elastase at 24
C. Gels were run in duplicate and stained by Coomassie blue (left) and
glycostaining (right). Lane 1, marker (M); lane 2, hIL-34FL:hCSF1-RD1-D5 before cleavage (); lane 3, hIL-34FL:hCSF1-RD1-D5 after 2.5 hr incubation with elastase
(+); and lane 4, elastase (C, control). While forming a complex, both hCSF-1RD1-D5 (band 1, 75 kDa) and hIL-34FL (band 3, 37 kDa) can be truncated to species
of lower MW (labeled as hCSF-1RTRUNC, band 2, 50 kDa, and hIL-34TRUNC, band 4, 23 kDa). In the case of hIL-34FL, truncation results in an almost complete loss
of glycostain signal.
(B) MALDI-TOF/TOF analysis of hCSF1-RD1-D5 (1), hCSF-1RTRUNC (2), hIL-34FL (3), and hIL-34TRUNC (4) bands cut from a Coomassie-stained SDS-PAGE gel.
Peptides identified by mass spectrometry are shown as black boxes and are mapped on hCSF-1RD1-D5 (blue) and hIL-34FL (red, predicted unstructured region
in purple). Glycans structurally confirmed by crystallographic data (Ma et al., 2012) are shown as yellow lines. Predicted glycans, using the netNglyc server for
N-linked glycans (Gupta et al., 2004) and the netOglyc server for O-linked glycans (Julenius et al., 2005), are marked by an asterisk. See also Table S2.
(C) Edman degradation of truncated hIL-34FL and hCSF-1RD1-D5 after incubation with elastase. Identified N termini for hIL-34TRUNC and hCSF-1RTRUNC are
identical to the native N termini of hIL-34FL and hCSF-1RD1-D5.
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Extracellular Complex of Human IL-34 with CSF-1Rmechanistic requirements of CSF-1R activation and, by extrap-
olation, that of other homologous RTK-III family members. This
is particularly opportune in light of the recent tremendous
progress in our understanding of the assembly principles of
extracellular RTK-III with cognate cytokines and their impact
on rationalizing RTK-III evolution and role in cancer and inflam-
mation (Verstraete and Savvides, 2012).
In this study, we have built upon recent structural work dis-
secting IL-34 and CSF-1 complexes with CSF-1R to provide
the missing link toward a possible consensus of the activation
principles of CSF-1R (Chen et al., 2008; Elegheert et al., 2011;
Liu et al., 2012; Ma et al., 2012). Structural studies thus far
have elucidated the structure of human and mouse IL-34
and provided details of the IL-34 interaction epitope on
CSF-1R accommodated by a grapple formed by the CSF-
1RD2-D3 module (Liu et al., 2012; Ma et al., 2012). A compar-
ison of the mIL-34 and mCSF-1 interaction sites on mouse
CSF-1R reveals coverage of the same general footprint but
with distinct interactions in each case (Liu et al., 2012).
Such detailed comparison of interaction epitopes is not yet
available for the human counterparts because of the absence
of a high-resolution structure for the human CSF-1:CSF-1R
complex.534 Structure 21, 528–539, April 2, 2013 ª2013 Elsevier Ltd All rightsOur hybrid structural analysis combining SAXS and EM
studies of full-length human IL-34 and a functional truncation
mutant thereof lacking 50 amino acids at the C terminus, in
complex with the full-length hCSF-1R ectodomain, has sought
to provide insights into the structural role of the membrane-
proximal domains D4 and D5 in CSF-1R in complex formation
and to provide views of the complete extracellular complexes.
In addition, we interrogated the structural role of the C-terminal
segment of IL-34 in complex formation and investigated its
biochemical properties.
Our structural studies have shown that dimerization of CSF-1R
by IL-34 evokes receptor-receptor contacts between adjacent
membrane-proximal D4 domains in CSF-1R, while D1 and
D5 extend away from the core of the complex. Importantly, the
IL-34:CSF-1R extracellular assembly is strikingly similar in
geometry and molecular principles employed to the CSF-
1:CSF-1R complex (Elegheert et al., 2011). The biological
implications of these observations are profound because they
now allow us, in conjunction with the plethora of structural and
biochemical studies of CSF-1 and IL-34 interactions with
cognate and noncognate CSF-1R (Chen et al., 2008; Elegheert
et al., 2011, 2012; Lin et al., 2008; Liu et al., 2012; Ma et al.,
2012), to establish a consensus for the assembly of signalingreserved
Figure 6. Overview of RTKIII Full Ectodo-
main Complexes with Cognate Cytokines
Left: solution SAXS structure of the IL-34:CSF-1R
complex. Middle left: solution SAXS structure of
the CSF-1:CSF-1R complex. Middle right: crystal
structure of the SCF:Kit complex (PDB ID code
2E9W). Right: crystal structure of the Flt3L:Flt3
complex (PDB ID code 3QS9). Transmembrane
helix regions of opposing receptors are shown
as rectangular blocks in gray. Not shown are the
intracellular split-kinase domains of the receptors,
which become phosphorylated upon cytokine-
induced receptor dimerization.
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Extracellular Complex of Human IL-34 with CSF-1Rcomplexes of CSF-1R by two distinct cytokine ligands. In the first
instance, dimeric CSF-1 and IL-34 each offer specific receptor
binding sites leading to initial ternary complexes targeting the
D2-D3 modules of CSF-1R (Chen et al., 2008; Elegheert et al.,
2011; Liu et al., 2012; Ma et al., 2012). This initial complex primes
homotypic receptor interactions in dimerized CSF-1R between
conserved sequence fingerprints localized in CSF-1RD4 to drive
assembly of a cooperative high-affinity complex (Elegheert et al.,
2011). We note that equivalent receptor homotypic interactions
have been confirmed in the homologous KIT (Yuzawa et al.,
2007) and PDGFRb (Yang et al., 2008), and in VEGFR (Kisko
et al., 2011; Ruch et al., 2007; Yang et al., 2010), from the related
RTK-V family. With the exception of Flt3, all RTK-III and RTK-V
members carry a conserved dimerization sequence fingerprint
in D4 or D7 (Verstraete et al., 2011b). Recent studies employing
an engineered monomeric variant of hCSF-1, dimeric hCSF-1,
and truncation ectodomain variants of hCSF-1R have deconvo-
luted the positive cooperativity of hCSF-1:hCSF-1R complexes
into modular contributions stemming from an initial encounter
complex (with low mM affinity), the dimer plasticity of hCSF-1
(contributing one order of magnitude to the KD), and receptor
ectodomain contacts at the level of D4 (improving the KD by
1-2 orders of magnitude) (Elegheert et al., 2012). Whereas
such detailed studies are not yet available for IL-34, binding
studies have already shown that the membrane-proximal
domains in CSF-1R contribute at least one order of magnitude
to the affinity of the extracellular complex (Liu et al., 2012;
Ma et al., 2012). Furthermore, hIL-34 displays plasticity in its
dimeric assembly as shown via the structure of its complex
with Fab fragments (Ma et al., 2012). Such structural plasticity
has already been observed in all other helical cytokines acti-
vating RTK-III (Elegheert et al., 2012; Verstraete et al., 2011b;
Yuzawa et al., 2007) and has been proposed as a common
mechanistic element of RTK-III activation (Verstraete and
Savvides, 2012).
The advent of a structural view of the complete IL-34:CSF-1R
extracellular complex has essentially brought the spectrum of
full-length ectodomain complexes of RTK-III with helical cyto-
kines to full circle (Figure 6). This collection of structures now
provides the most direct evidence to date that similarly sized
dimeric helical cytokine ligands of RTK-III evolved to respondStructure 21, 528–539, April 2, 2013to conserved geometric requirements
for the productive alignment of mem-
brane proximal D4 and D5, thereby
coupling cytokine binding to intracellularactivation of the RTK-III kinase domains (Verstraete and Savvi-
des, 2012). We note in particular that the consensus feature in
all four RTK-III cytokines is their ability to bind to D3 of their
cognate RTK-III receptors, bringing the dimerized receptor
molecules within a critical distance of 60 A˚. IL-34 and CSF-1
offer perhaps the best evidence for this mechanistic principle.
Despite their greatly divergent sequences, IL-34 and CSF-1
establish strikingly similar extracellular assemblies with their
common receptor, CSF-1R (Figures 1 and 6), and appear to
have evolved to meet the activation requirements of CSF-1R.
We envisage that such insights may impact therapeutic
targeting of RTK-III, as efforts are beginning to shift toward
combined approaches, focusing both in the intracellular kinase
domains and the receptor ectodomains (Verstraete and Savvi-
des, 2012).
EXPERIMENTAL PROCEDURES
Production of Recombinant Human IL-34 and IL-34:CSF-1R
Complexes
Constructs, including coding sequences of full-length (hIL-34FL, residues
N21-P242) and truncated (hIL-34N21-P200, residues N21-P200) human inter-
leukin 34, each containing a C-terminal His6-tag, were cloned into the
pcDNA4TO vector (Invitrogen, Carlsbad, CA, USA). Human colony stimulating
factor 1 receptor ectodomains 1-3 (hCSF-1RD1-D3) and 1-5 (hCSF-1RD1-D5)
constructs containing C-terminal His6-tags were cloned into the pHLsec
vector (Aricescu et al., 2006). We used HEK293S GnTI-/- cells (Reeves et al.,
2002; Verstraete et al., 2011a), which lack N-acetylglucosaminyltransferase-I,
to establish stable tetracycline-inducible cell lines expressing hIL-34FL and
hIL-34N21-P200 with homogeneous GlcNAc2Man5 N-glycans. Because of
aggregation of unbound hIL-34, a coexpression protocol was established in
which hCSF-1RD1-D3 and hCSF-1RD1-D5 ectodomain constructs were tran-
siently transfected (Aricescu et al., 2006; Chang et al., 2007) into the stable
cell lines expressing hIL-34FL and hIL-34N21-P200. During transfection, tetracy-
cline and sodium butyrate were added to the transfection medium to ensure
coexpression of both ligand and receptor. Expression medium was harvested
after 5 days of expression and always contained the complex of interest
(hIL-34N21-P200:hCSF-1RD1-D3, hIL-34N21-P200: hCSF- 1RD1-D5, or hIL-34FL:
hCSF-1RD1-D5), together with an excess of receptor (hCSF-1RD1-D3 or hCSF-
1RD1-D5), which always expressed at higher levels than IL-34. Target com-
plexes were purified by immobilized metal affinity chromatography using a
Co2+-loaded TALON FF column (Clontech, Mountain View, CA, USA). Next,
eluted fractions were pooled and injected onto a Prep-Grade Hiload 16/60
SD-200 column (GE Healthcare, Waukesha, WI, USA). Peak fractions corre-
sponding to hIL-34N21-P200:hCSF-1RD1-D3, hIL-34N21-P200:hCSF-1RD1-D5, orª2013 Elsevier Ltd All rights reserved 535
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SAXS, and EM experiments described further.
Multiangle Laser Light Scattering
Determination of the molecular masses of hIL-34N21-P200:hCSF-1RD1-D3,
hIL-34N21-P200:hCSF-1RD1-D5, and hIL-34FL:hCSF-1RD1-D5 complexes was
performed by MALLS. Protein samples were injected into a high-pressure
liquid chromatography (HPLC)- (Shimadzu, Kyoto, Japan) FFF module (Wyatt
Technology, Goleta, CA, USA) equilibrated with a 20 mM HEPES (pH 7.5) and
150 mM NaCl buffer. The FFF module was coupled to an online UV detector
(Shimadzu), an 18-angle light scattering detector (DAWN HELEOS), and
a refractive index detector (Optilab T-rEX) (Wyatt Technology). Protein concen-
trations used were in the 1–10 mM range. An refractive index (RI) increment
value (dn/dc value) of 0.185 ml/g was used for the protein concentration and
molecular mass determination. FFF cross-flows were varied to optimize the
resolution of separation. Data analysis were carried out using the ASTRA V
software.
Small-Angle X-Ray Scattering
SAXS data were collected at the EuropeanMolecular Biology Laboratory - X33
beamline on the storage ring DORIS III at Deutsches Elektronen-Synchrotron
(DESY, Hamburg) (Blanchet et al., 2012; Roessle et al., 2007) and the ID 14-
3 beamline at European Synchrotron Radiation Faclilty (ESRF, Grenoble)
(Pernot et al., 2010). Measurements were carried out at 283 K (X33) or 293 K
(ID-14-3), within a momentum transfer range of 0.01 A˚1 < s < 0.6 A˚1, where
s = 4psin(q)/l and 2q is the scattering angle. Samples were measured at solute
concentrations of 1.5, 3.5, and 5 mg/ml in 50 mM Na2HPO4 (pH 7.5) and
100 mM NaCl for hIL-34N21-P200:hCSF-1RD1-D3. hIL-34N21-P200:hCSF-1RD1-D5
and hIL-34FL:hCSF-1RD1-D5 samples were recuperated from the MALLS
experiments described earlier and subsequently concentrated to 1, 2, and
3 mg/ml (hIL-34N21-P200:hCSF-1RD1-D5) or 0.5, 1, and 3 mg/ml (hIL-34FL:
hCSF-1RD1-D5) in 20 mM HEPES (pH 7.5) and 150 mM NaCl. No measurable
radiation damage was detected on comparison of eight (X33) or ten (ID14-3)
successive time frames with 15 s (X33) or 10 s (ID-14-3) exposures. Initial
data processing were performed at the beamlines using automatic protocols
developed at EMBL Hamburg (Franke et al., 2012). Buffer subtraction and
extrapolation to infinite dilution were performed by the program PRIMUS
(Konarev et al., 2003) in accordance with standard procedures. Merged
curves were generated using the low angle part of the lowest concentration
curve and the high angle part of the highest concentration curve. The Guinier
region was evaluated by PRIMUS using Guinier approximation (Guinier, 1939).
The Porod volume was evaluated using PRIMUS. The radius of gyration rg,
forward scattering I0, maximum particle dimension Dmax, and the distance
distribution function P(r) were evaluated using GNOM (Svergun, 1992). Molec-
ular masses of different constructs were calculated by comparison with
the reference BSA sample. Theoretical scattering patterns from available
structures and generated models, together with their respective discrepancy
to the experimental data, were calculated using CRYSOL (Petoukhov et al.,
2012; Svergun et al., 1995).
Ab Initio Modeling of SAXS Data
Ab initio shape reconstructions were performed using the bead modeling
programs DAMMIF (Franke and Svergun, 2009) for hIL-34N21-P200:hCSF-
1RD1-D5 and DAMMIN (Svergun, 1999) for hIL-34N21-P200:hCSF-1RD1-D3.
Both DAMMIF and DAMMIN were run ten times, imposing 2-fold symmetry.
The generated DAMMIF and DAMMIN models were subsequently averaged
with application of P2 symmetry, using the DAMAVER program suite (Volkov
and Svergun, 2003).
Rigid-Body Modeling of SAXS Data
The online version of SASREF (Petoukhov et al., 2012; Petoukhov and Sver-
gun, 2005) was used to perform rigid-body refinements of the hIL-34N21-P200:
hCSF-1RD1-D3, hIL-34N21-P200:hCSF-1RD1-D5, and hIL-34FL:hCSF-1RD1-D5
complexes. In each case, data up to 0.25 A˚1 was used and P2 symmetry
was imposed. For both hIL-34N21-P200:hCSF-1RD1-D3 and hIL-34N21-P200:
hCSF-1RD1-D5, the crystal structure of hIL-34 bound to hCSF-1RD2-D3 was
taken (Ma et al., 2012) (Protein Data Bank [PDB] ID code 4DKD) as one rigid
body, whereas D1 was allowed tomove with a contact restraint of 5 A˚ between536 Structure 21, 528–539, April 2, 2013 ª2013 Elsevier Ltd All rightsits C terminus and the N terminus of hCSF-1RD2-D3. Five GlcNAc2Man5
N-glycans, treated as rigid bodies, were added to the model with contact
restraints of 5 A˚ to truncated asparagine residues N75 on hIL-34 and N73,
N153, N240, and N275 of hCSF-1RD1-D3. The C-atoms of these N-glycans
were changed to Ca-atoms to prevent clashes during SASREF runs.
The native glycosylation state of the hIL-34:hCSF-1RD1-D3 complex was
inferred from the hIL-34:hCSF-1RD1-D3 structure (Ma et al., 2012). For the
hIL-34N21-P200:hCSF-1RD1-D5 SASREF runs, 3D models for hCSF-1RD4 and
hCSF-1RD5 were generated using the online version of I-Tasser (Roy et al.,
2010). These models were made using D4 and D5 of the KIT receptor (Yuzawa
et al., 2007) as respective templates, with a sequence identity/coverage of
30%/97% and 30%/90%, respectively. Ambiguous contact distances
between D4 and D4’ were imposed based on the structure of the SCF:KIT
complex (PDB ID code 2E9W) and the conserved Arg-Glu motive present in
the hCSF-1RD4 sequence. Finally, an extra N-glycan was added to N353
of hCSF-1RD4, based on an N-glycosylation prediction performed by the
netNglyc server (Gupta et al., 2004). The same approach was used to reana-
lyze SAXS data from a previous study on hCSF-1:hCSF-1R complexes
(Elegheert et al., 2011). Rigid-body runs were carried out using the online
version of SASREF. The same set of rigid bodies and contact restraints
(including glycans on N73, N153, N240, N275, and N353 of hCSF-1RD1-D5)
was used as described for hIL-34N21-P200:hCSF-1RD1-D5, except for the
replacement of hIL-34:hCSF-1RD2-D3 with mCSF-1:mCSF-1RD2-D3 taken
from PDB ID code 3EJJ (Chen et al., 2008). V153, G240, and I275 of mCSF-
1RD2-D3 were truncated to Ca during SASREF runs and afterward mutated to
asparagine residues to provide identical glycosylation spots as found in
hCSF-1RD2-D3.
Energy Minimization of SASREF Rigid-Body Models
To obtain structures that were as chemically correct as possible, missing
residues and gaps present in the SASREF rigid-body models were added,
and physical linkages were made between glycosylated asparagine residues
and their GlcNAc sugars, followed by a round of energy minimization. All-atom
simulations were conducted using NAMD 2.8 (Phillips et al., 2005), relying on
the CHARMM force field (Guvench et al., 2008, 2009, 2011; MacKerell et al.,
1998; Mackerell et al., 2004). Additional parameters were introduced to
describe the asparagine-GlcNAc linkage, by analogy to existing parameters
(see Table S3). Topologies and initial structures were constructed with VMD
(Humphrey et al., 1996) based on the structures obtained from SASREF refine-
ment. Missing loops were modeled using FREAD (Choi and Deane, 2010).
Resulting all-atom structures were then energy minimized in a stepwise
fashion, each time doing 5,000 minimization steps, while gradually lifting
constraints. First, all GlcNAc glycan moieties and amino acids in modeled
loops were unrestrained, while position restraints were applied to all other
atoms (with a harmonic force constant of 5 kcal/mol/A˚2). Subsequently, posi-
tion restraints were only applied to mannose residues along with a distance
restraint (5.2 A˚ with a harmonic force constant of 10 kcal/mol/A˚2) on the salt
bridges between E76 and R72 of opposing hCSF-1RD4 chains. In the next
steps, these constraints were lifted, first by 10-fold reduction of the force
constant and then by turning off constraints all together, finalizing by a
5,000-step minimization without constraints. All simulations were done with
a generalized Born implicit solvent model of water (Tanner et al., 2011). Finally,
CRYSOL was used to calculate scattering patterns of the energy-minimized
SASREF models and their discrepancy to the experimental SAXS data. No
significant changes in respective c2 values were detected after addition of
missing loops and energy minimization of the SASREF models. c2 values
presented in Figures 2, 3, and 4 and Table S1 represent the c2 values after
energy minimization.
Negative Stain Electron Microscopy
For preparation of negatively stained hIL34FL:hCSF-1RD1-D5 complex, purified
sample with a concentration of 0.1 mg/ml in HEPES buffer (20 mMHEPES and
150 mM NaCl [pH 7.4]) was applied to the clear side of carbon on a carbon-
mica interface and stained with Nano-W from nanoprobes. Images were
recorded under low-dose conditions with a JEOL 1200 EX II microscope at
100 kV and at a 52,974x magnification with an Orius SC600 Gatan CCD
camera. Images were binned to a pixel size of 3.4 A˚ at the object scale. A
data set of circa 12,000 96*96 pixel subframeswas semiautomatically selectedreserved
Structure
Extracellular Complex of Human IL-34 with CSF-1Rwith the boxer routine of EMAN (Ludtke et al., 1999), CTF-corrected with
CTFFIND3 (Mindell and Grigorieff, 2003), and bsoft (Heymann et al., 2008)
and low-pass-filtered at 15 A˚ resolution. The translationally centered data
set was subjected to multivariate statistical analysis (MSA) and classification
with Imagic-5 (van Heel et al., 1996). Characteristic class averages with the
best overall quality were used as a set of references for multireference
alignment followed by MSA and classification. After several iterations and
obtainment of stable classes, the inside of each class of individual frames
was sorted according to the correlation with the respective class average,
and the fifty best subframes of each class were summed up into a second
reference used for realignment and production of improved class averages.
These class averages were aligned against projections of the SAXS model
of the hIL-34N21-P200:hCSF-1RD1-D5 complex filtered to 30 A˚ resolution for
visual comparison.
Limited Proteolysis, Edman Degradation, and MALDI-TOF/TOF
MSMS Analysis
For the limited proteolysis experiments, 43 ml of hIL-34FL:hCSF-1RD1-D5
(0.1 mg/ml in 20 mM HEPES and 150 mM NaCl [pH 7.5]) was mixed with
2 ml elastase (Sigma-Aldrich, St. Louis, MO, USA; 500 mg/ml in 0.1 M Tris-HCl
[pH 8]) and 5 ml 10X protease buffer (1 M Tris-HCl [pH 8]). Proteolysis was
carried out at 24C and was stopped after 2.5 hr by boiling at 95C for
10 min after addition of Laemmli buffer and b-mercaptoethanol. The experi-
ment was run in duplicate and analyzed using SDS-PAGE followed by
Coomassie staining and glycostaining (Pierce Glycoprotein Staining Kit,
Thermo Scientific, Waltham, MA, USA), respectively.
Coomassie-stained bands were cut out and digested with trypsin and/or
chymotrypsin (Promega, Madison, WI, USA) overnight at 37C. The next
day, peptides were extracted by adding 40 ml 60% acetonitrile/0.1% HCOOH
to the gel pieces. After drying of the peptide mixture, peptides were redis-
solved in 10 ml 0.1% formic acid, mixed with 3 mg/ml a-cyano hydroxycin-
namic acid (Sigma-Aldrich) in 50% acetonitrile/0.1% TFA, and analyzed by
mass spectrometry using a 4800 plus TOF/TOF analyzer (Applied Biosystems,
Foster City, CA, USA). N-terminal sequence determination of equivalent bands
was performed by automated Edman degradation on a Procise model 494
sequencer instrument, equipped with an on-line HPLC system consisting of
a 140C Microgradient pump and a 785A programmable absorbance detector
(all from Applied Biosytems). The analysis was performed with acid delivery
in the gas phase after electroblotting the protein sample to a polyvinylidene
difluoride membrane (Applied Biosystems). Intact protein analysis of purified
hIL-34FL in phosphate buffer (50 mM Na2HPO4 and 300 mM NaCl) was
performed using a 4800 plus TOF/TOF analyzer (Applied Biosystems) acting
in linear mode. To improve ionization, the sample was diluted 10-fold in
0.1% formic acid and directly spotted on a MALDI target plate.
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